Guys they are not putting out any news as I have already told you. Joe has always over-promised and under-delivered. He does not want to do that any more. They got the exemption from the SEC and they filed the IND. They are now working on getting the NGIO IPO. That's it. The SEVC was investigating every COVID company and we got the exemption because they realized that this is based on real science not hype or BS. There are still many nay sayers but they are moving forward. Just be a little more patient and if you are a lo0ng you should be very well rewarded. Do the math. The IPo's range is between $9-$11. Do the math currently about 104 million shares in NuGenerex plus the 5 million that are being sold plus the ten million in warrants that are being issued- let's round it up to 120 million shares at $10-That's 1.2 billion dollars! Generex owns about 64 to 65 million shares and at $10/share that's about 640-650 million dollars. That's nearly 30x times the current market cap without including the valuable alternate technologies including the company I founded or Olaregen Therapeutix LLC (someone made a comment about Anthony Dolisi-I hired him!) but I am not involved in the company in any way form or shape to be clear except as a major shareholder. So that's the upside potential. Incidentally when that IPO happens Generex becomes eligible for NASDAQ listing itself. If you want to be on the wrong side of that train when it begins then so be it. Everyone have a nice day and cheers to all of you. Hang in there and you will be rewarded for your loyalty. I am long at $2.50/share--remember that
(8)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links